Chronic Myeloid Leukemia News The FDA has approved bosulif (bosutinib) for patients aged 1 year or older with chronic phase Ph+ CML.
Patients with CML have a higher risk of albuminuria if they receive dasatinib rather than other TKIs, a study suggests.
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest.
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Chronic myeloid leukemia patients treated with nilotinib instead of other tyrosine kinase inhibitors may have a greater risk of developing diabetes and hyperlipidemia.
Researchers found a higher risk of VTE in patients with cancer and COVID-19 who were receiving systemic cancer therapies.
Industry-sponsored cancer trials are more likely to have consent documents translated to languages other than English, a study suggests.
In an analysis of more than 10,000 cancer clinical trials, less than half had results reported within 1 year of trial completion.
New research suggests that, in the United States, cancer was underdiagnosed during the first year of the COVID-19 pandemic.
Excessive alcohol consumption may be common among cancer survivors and cancer patients currently receiving treatment, a new study suggests.
LGBTQ+ adolescents and young adults with cancer face unique challenges in the health care setting, a review suggests.
Certain factors may increase the risk of severe COVID-19 in patients with cancer, research suggests.
As many as 55% of patients with cancer may be affected by food insecurity.
Engaging in vigorous physical activity for 3 to 4 minutes per day is associated with a decrease in the risk of cancer among adults who typically don’t exercise, new research suggests.
Housing insecurity can impede patients’ access to cancer screening, treatment, and survivorship care, increasing the risk of poor outcomes.
Researchers have estimated that failed oncology trials cost about $50 billion to $60 billion each year.
Cancer patients may be particularly susceptible to transportation-related disruptions in care.
Prior authorization requirements for oral cancer drugs on Medicare part D formularies have increased in recent years, research suggests.
Getting less than 6 hours of sleep each night was associated with an increased risk of cancer in a large study.
Researchers studied 22 oral cancer drugs and found that wastage due to dose modifications or discontinuations resulted in a mean cost of $4290 per patient.
Load More